Fenofibrate in the treatment of dyslipidemia: A review of the data as they relate to the new suprabioavailable tablet formulation
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference124 articles.
1. AHA dietary guidelines;Krauss;Circulation,2000
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);JAMA,2001
3. Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanisms;Levine;N Engl J Med,1995
4. Drug treatment of dyslipidemias: Practical guidelines for the primary care physician;Bays;Heart Dis Stroke,1992
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Protective Effect of Pemafibrate Treatment against Diabetic Retinopathy in Spontaneously Diabetic Torii Fatty Rats;Biological and Pharmaceutical Bulletin;2024-03-27
2. Quantitative Investigation of Intestinal Drug Absorption Enhancement by Drug-Rich Nanodroplets Generated via Liquid–Liquid Phase Separation;Molecular Pharmaceutics;2024-03-19
3. Repositioning of the Antihyperlipidemic Drug Fenofibrate for the Management of Aeromonas Infections;Microorganisms;2024-02-25
4. Advanced nanomedicines for the treatment of age-related macular degeneration;Nanoscale;2024
5. Current Treatments for Diabetic Macular Edema;International Journal of Molecular Sciences;2023-05-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3